A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

Takeda is promoting U.S. chief Julie Kim to be its next CEO. AstraZeneca and Daiichi's Enhertu has won an FDA nod to expand into HER2-ultralow breast cancer. | Takeda is promoting U.S. chief Julie Kim ...

West Pharmaceutical Services (NYSE:WST – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a report released on Friday. Other analysts ...

EXTON, Pa. - West Pharmaceutical Services, Inc. (NYSE:WST), a company specializing in solutions for injectable drug ...

Fifth Third Bancorp lifted its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 2.0% ...

The Hancock County Commission will be receiving additional funds as part of an antitrust lawsuit filed by the State of West Virginia against two pharmaceutical companies. According to a letter from ...

CHARLESTON, W.Va. — West Virginia looks to receive as much as $55 million from the announced $74 billion dollar settlement ...

OxyContin maker Purdue Pharma and its owners agreed to pay up to $7.4 billion in a new settlement, officials in Mass. and ...

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the ...